Skip to main content
Toggle navigation
Login
Home
Favorite
Like
Post
Print
Elizabeth Grunewald
Winicker Norimed GmbH, Nuremberg, Germany, Germany
Poster(s):
(B-106) Adherence to risk minimization measures for alemtuzumab use in Multiple Sclerosis: a drug utilisation study in four European countries
Monday, August 25, 2025
11:30 AM - 1:00 PM
ET